Mineralys Therapeutics Management
Management criteria checks 0/4
Mineralys Therapeutics' CEO is Jon Congleton, appointed in Nov 2020, has a tenure of 3.5 years. total yearly compensation is $5.36M, comprised of 9.7% salary and 90.3% bonuses, including company stock and options. directly owns 2.11% of the company’s shares, worth $14.97M. The average tenure of the management team and the board of directors is 1.3 years and 2.6 years respectively.
Key information
Jon Congleton
Chief executive officer
US$5.4m
Total compensation
| CEO salary percentage | 9.7% |
| CEO tenure | 3.5yrs |
| CEO ownership | 2.1% |
| Management average tenure | 1.3yrs |
| Board average tenure | 2.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$91m |
| Dec 31 2023 | US$5m | US$517k | -US$72m |
| Sep 30 2023 | n/a | n/a | -US$57m |
| Jun 30 2023 | n/a | n/a | -US$40m |
| Mar 31 2023 | n/a | n/a | -US$35m |
| Dec 31 2022 | US$2m | US$417k | -US$30m |
| Sep 30 2022 | n/a | n/a | -US$28m |
| Dec 31 2021 | US$675k | US$346k | -US$19m |
Compensation vs Market: Jon's total compensation ($USD5.36M) is above average for companies of similar size in the US market ($USD3.38M).
Compensation vs Earnings: Jon's compensation has increased whilst the company is unprofitable.
CEO
Jon Congleton (60 yo)
3.5yrs
Tenure
US$5,355,257
Compensation
Mr. Jon Congleton serves as Chief Executive Officer and Director at Mineralys Therapeutics, Inc. since November 2020. He serves as an Operating Partner at Catalys Pacific. He was the Chief Executive Office...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 5yrs | US$630.13k | no data | |
| CEO & Director | 3.5yrs | US$5.36m | 2.11% $ 15.0m | |
| CFO & Secretary | 2.2yrs | US$2.19m | 0.71% $ 5.0m | |
| Chief Medical Officer | 3.3yrs | US$2.35m | 0.13% $ 956.0k | |
| Executive Vice President of Operations | 1.3yrs | no data | no data | |
| Vice President of Human Resources | less than a year | no data | no data | |
| Senior Vice President of CMC | no data | no data | no data | |
| Senior Vice President of Quality Assurance | no data | no data | no data | |
| Senior Vice President of Regulatory Affairs | no data | no data | no data | |
| Senior Vice President of Clinical Operations | 1.3yrs | no data | no data | |
| Chief Business Officer | less than a year | no data | no data | |
| Senior Vice President of Clinical Development | less than a year | no data | no data |
1.3yrs
Average Tenure
53yo
Average Age
Experienced Management: MLYS's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Executive Chairman | 5yrs | US$630.13k | no data | |
| CEO & Director | 3.5yrs | US$5.36m | 2.11% $ 15.0m | |
| Independent Director | 2yrs | US$601.97k | 0% $ 0 | |
| Independent Director | less than a year | US$427.02k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$607.30k | 0% $ 0 | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Independent Director | 3.3yrs | US$560.79k | no data | |
| Independent Director | less than a year | US$428.52k | 0% $ 0 | |
| Member of Clinical Advisory Board | no data | no data | no data | |
| Independent Director | 2yrs | US$611.91k | 0% $ 0 | |
| Member of Clinical Advisory Board | no data | no data | no data |
2.6yrs
Average Tenure
55yo
Average Age
Experienced Board: MLYS's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.